CAPTRUST Financial Advisors
MITO

CAPTRUST Financial Advisors’s Stealth BioTherapeutics Corp. ADS MITO Stock Holding History

CAPTRUST Financial Advisors’s Portfolio MITO Stock Details MITO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,000
Closed -$5K – 2274
2022
Q3 		$5K Hold
15,000
– – ﹤0.01% 2042
2022
Q2 		$4K Buy
+15,000
New +$5.16K ﹤0.01% 4250

CAPTRUST Financial Advisors's MITO Position: Q4 2022 in Review

CAPTRUST Financial Advisors sold out of Stealth BioTherapeutics Corp. ADS (MITO) in Q4 2022, closing a stake of 15,000 shares — an estimated $5K sold.

CAPTRUST Financial Advisors first reported a position in MITO in Q2 2022 and held it in 2 quarters. The position peaked at $5K in Q3 2022. 0 funds tracked by Wall St. Rank hold MITO as of Q4 2022.

  • CAPTRUST Financial Advisors reported no remaining Stealth BioTherapeutics Corp. ADS position as of Q4 2022 after selling out during the quarter.
  • CAPTRUST Financial Advisors sold 15,000 Stealth BioTherapeutics Corp. ADS shares in Q4 2022, an estimated $5K.
  • CAPTRUST Financial Advisors first reported a position in Stealth BioTherapeutics Corp. ADS in Q2 2022 and held it in 2 quarters.
  • CAPTRUST Financial Advisors's Stealth BioTherapeutics Corp. ADS position peaked at $5K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Stealth BioTherapeutics Corp. ADS as of Q4 2022.

Based on CAPTRUST Financial Advisors's 13F filing for Q4 2022, filed 15 Feb 2023.